China · Delayed Price · Currency is CNY ChengDa Pharmaceuticals Statistics
Total Valuation
SHE:301201 has a market cap or net worth of CNY 5.35 billion. The enterprise value is 4.42 billion.
| Market Cap | 5.35B |
| Enterprise Value | 4.42B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | Jul 15, 2026 |
Share Statistics
SHE:301201 has 151.47 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 151.47M |
| Shares Outstanding | 151.47M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | -0.34% |
| Owned by Insiders (%) | 40.64% |
| Owned by Institutions (%) | 1.74% |
| Float | 80.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.17 |
| PB Ratio | 2.55 |
| P/TBV Ratio | 2.60 |
| P/FCF Ratio | 748.22 |
| P/OCF Ratio | 99.41 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 76.09, with an EV/FCF ratio of 618.11.
| EV / Earnings | n/a |
| EV / Sales | 9.23 |
| EV / EBITDA | 76.09 |
| EV / EBIT | n/a |
| EV / FCF | 618.11 |
Financial Position
The company has a current ratio of 6.53, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.53 |
| Quick Ratio | 5.47 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.89 |
| Debt / FCF | 7.23 |
| Interest Coverage | -15.85 |
Financial Efficiency
Return on equity (ROE) is -1.06% and return on invested capital (ROIC) is -1.44%.
| Return on Equity (ROE) | -1.06% |
| Return on Assets (ROA) | -0.45% |
| Return on Invested Capital (ROIC) | -1.44% |
| Return on Capital Employed (ROCE) | -0.79% |
| Weighted Average Cost of Capital (WACC) | 3.19% |
| Revenue Per Employee | 727,482 |
| Profits Per Employee | -34,067 |
| Employee Count | 659 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 2.15 |
Taxes
| Income Tax | -1.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.24% in the last 52 weeks. The beta is -0.19, so SHE:301201's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | +24.24% |
| 50-Day Moving Average | 34.75 |
| 200-Day Moving Average | 40.20 |
| Relative Strength Index (RSI) | 50.25 |
| Average Volume (20 Days) | 9,235,066 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301201 had revenue of CNY 479.41 million and -22.45 million in losses. Loss per share was -0.15.
| Revenue | 479.41M |
| Gross Profit | 136.67M |
| Operating Income | -16.99M |
| Pretax Income | -24.06M |
| Net Income | -22.45M |
| EBITDA | 58.13M |
| EBIT | -16.99M |
| Loss Per Share | -0.15 |
Balance Sheet
The company has 985.40 million in cash and 51.72 million in debt, with a net cash position of 933.68 million or 6.16 per share.
| Cash & Cash Equivalents | 985.40M |
| Total Debt | 51.72M |
| Net Cash | 933.68M |
| Net Cash Per Share | 6.16 |
| Equity (Book Value) | 2.10B |
| Book Value Per Share | 13.88 |
| Working Capital | 1.12B |
Cash Flow
In the last 12 months, operating cash flow was 53.86 million and capital expenditures -46.70 million, giving a free cash flow of 7.16 million.
| Operating Cash Flow | 53.86M |
| Capital Expenditures | -46.70M |
| Depreciation & Amortization | 75.13M |
| Net Borrowing | -36.52M |
| Free Cash Flow | 7.16M |
| FCF Per Share | 0.05 |
Margins
Gross margin is 28.51%, with operating and profit margins of -3.54% and -4.68%.
| Gross Margin | 28.51% |
| Operating Margin | -3.54% |
| Pretax Margin | -5.02% |
| Profit Margin | -4.68% |
| EBITDA Margin | 12.13% |
| EBIT Margin | -3.54% |
| FCF Margin | 1.49% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.55%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.55% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | 0.51% |
| Earnings Yield | -0.42% |
| FCF Yield | 0.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 7, 2023. It was a forward split with a ratio of 1.6.
| Last Split Date | Jul 7, 2023 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |